In addition, we examined reports of neuropathologic studies conducted on patients with GD who developed parkinsonism and compared the findings to heterozygous GBA1-mutation carriers with parkinsonism, which are more frequently examined. This evidence concerns the gene GBA1 and Parkinson disease.